Duopharma Biotech Berhad is poised for collaborative growth after a productive roundtable in Doha, Qatar. The session, led by Group Managing Director Leonard Ariff Abdul Shatar, explored “Scaling Up Healthcare with Innovative Opportunities” and emphasized the importance of Halal pharmaceuticals.
The event, attended by Qatari officials and industry leaders, highlighted the Malaysian Halal standard MS 2424 and the OIC standard SMIIC 50-1, advocating for Halal quality assurance.
Duopharma biotech pursues collaboration opportunities
Leonard Ariff stressed the synergy between Halal practices and ESG standards, underscoring Duopharma Biotech’s commitment to inclusive healthcare through Halal-certified products. The company’s vision aligns with global sustainability goals and patient-centric values, offering diverse treatment options.
Malaysian Ambassador to Qatar, HE Zamshari Shaharan, underscored the importance of strengthening Qatar-Malaysia trade relations, a sentiment echoed by Prime Minister Anwar Ibrahim during his visit. The growing interest in Halal products in Qatar signals potential partnerships.
Duopharma Biotech’s dedication to Halal pharmaceuticals is evident in its symposiums, fostering international dialogue and setting industry benchmarks. The company’s pioneering efforts since 1999 have led to a range of Halal-certified health supplements and the distinction of being the first to receive Halal certification for an oncology product, aligning with the Malaysian Halal Pharmaceuticals Standard MS 2424:2019.
The upcoming Halal Pharmaceuticals Symposium in September 2024 marks another step towards integrating Halal pharmaceuticals into global healthcare.
Follow us on:
Read More News at #latestmalaysia #BusinessNews and #WorldFuture
